The effect on quality of life (QOL) 
Introduction
Laryngeal cancer is one of the most common tumors of the respiratory tract. Chemoradiotherapy and surgery are believed to offer similar final outcomes; however, laryngectomy impairs quality of life (QOL) as a result of definitive tracheostomyand the lossof vocalspeech.'
Organ preservation protocols focusing on larynx preservation are widely offered to patients with T3 tumors without massive invasionof cartilage.'For patientswith more advanced tumors, the effectiveness of chemoradiotherapycomparedwith total laryngectomy iscontroversial, with an increasing acceptance of laryngectomy as a more effective strategy.' In arriving at a therapeutic modality, most physicians and patients consider QOL concerns to be as important as long-term survival. ' One factor favoring organ preservation treatments is the possibilityof breathing and talking with natural organsbut with ahigher rate ofadverseeffects relatedto thelong-termsequelaeofchemotherapyor radiotherapy, such as xerostomia and swallowing disorders. Laryngectomy, therefore, is not usually considered to be the first alternative due to attitudes related to poorer QOL.
Many studies have evaluated QOL outcomes in cohorts of patients who underwent organ preservation or laryngectomy; few randomized controlled trials, however, have compared the results between both strategies. The fewrandomized comparisons that have been conducted showsimilar or better results in organ preservation treatments.Y Most of this information comesfrom QOLassessmentsin Englishliterature and primarily in patients from developed countries with specific social and economic characteristics.
Data from patients in developing countries and in different cultural settings are lacking. Despite QOL findingscoming from BrazilianInvestigators," data are scarceforSpanish-speakingcountries.v" Because QOL assessments changeaccordingtosocioeconomic factors, resultsaredifficulttoextrapolate to different populations.
The aim of this study was to evaluate the QOL outcomesofpatients with advanced laryngeal tumors who were treated with laryngectomy or organ preservation protocols in Latin America.
www.entjournal.com • 83 Ten patients (71.4%) who were treated with an organ preservation protocol needed definitive tracheostomy. and halfof the patients in each group had a gastrostomy tube. A total of22.9% had recurrence at the time of the interview. The only baseline difference between the two groups was that the group that underwent laryngectomy had a lower proportion of adjuvant chemoradiotherapy.
The burden ofsymptoms on the UW-QOLinstrument is shown in table 2. The most important factors on QOL for both groups were speech and activity, respectively. In the laryngectomy group, the next most important factors were appearance, taste, pain , and recreation; for the organ preservation group, the next most important factors were saliva, recreation, mood, and swallowing. The descriptive distribution of domains ofthe UW-QOL is shown in table 3.
Statistically significant differences were found in activity and speech, with worse scores for the laryngectomy group. Although not statistically significant, . more than a lO-point decrement (clinically relevant) was found in the shoulder, anxiety, swallowing, taste , and appearance domains among the patients who underwent laryngectomy, and in the saliva domain among the patients who received an organ preservation protocol. Both social and physical subscales had a dif- 
Patients and methods
This study was approved by the Ethics in Research Committee of the Hospital Pablo Toben Uribe, and informed consent was obtained for inclusion. Patients with laryngeal cancer classified as stage III or IV who were treated under organ preservation protocols (including chemoradiotherapy or exclusive radiotherapy) or laryngectomy were included. The choice of treatment was at the discretion of the treating physicians, who were following the guideline established by the' National Comprehensive Cancer Network.I I All patients must have completed their definitive treatment and were being followed at the Head and Neck Section of the Hospital Pablo Toben Uribe Oncology Unit, Medellin; Hospital Universitario de Caldas, Manizales; and the Hospital Mederi, Bogota, Colombia.
Patients with physical impairments that prevented reading, hearing, or understanding the QOL scale, those for whom the last treatment date was more than 5 years ago, and those who did not consent to participate were excluded.
Patient data were collected prospectively during routine clinical visits from February 2013 to January 2015.
To evaluate QOL outcomes, we used the Spanish validated version of the University of Washington Quality of Life (UW-QOL) questionnaire for patients with head and neck cancer, assisting those patients who could not read the instrument to obtain the relevant information. This instrument has been evaluated in many clinical settings and has been translated to and validated in many languages.P:"
The UW-QOLhas three domains (symptom, priorityof symptoms, and global health-related QOL) with separate items (pain, appearance, activitylevel, recreation, swallowing, chewing, speech, shoulder function, taste, and saliva production) scored on a scale from 0 to 100.
The burden of symptoms was defined following the coding instruction of the UW-QOL instrument, according to the rank that patients gave to each symptom. We also obtained patient demographics and information on stage and European Cooperative Oncology Group functional status from the clinical charts.
The categorical variables are presented as percentages and ranges, and the continuous variables are shown as the means and standard deviation. For the analysis, some continuous variables were categorized. The significance level was set at p <
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Due to the characteristics ofthis preparation, notoxic effectsare to ba axpect ed wit h an oticoverdose ofOTOVEL. trials and meta-analyses.P-" The introduction ofthese protocols relegated laryngectomy to a secondary method in the treatment ofadvanced tumors due to the negative impact of a definitive tracheostomy with the loss ofvocal ability and the related consequences of this procedure on appearance." However, for transglottic tumors with massive cartilage invasion, laryngectomy has recently been demonstrated to offer advantages in terms ofdisease-free and overall survival compared with chemoradiotherapy, producing a renaissance of indications for and the use of total laryngectorny." Nonetheless, patients and physicians are aware of the negative effects of total laryngectomy on QOL, which impedes its wide use.
QOL assessments have been made in patients who underwent laryngectomy or organ preservation protocols and have shown similar or better results with organ preservation in the most recent studies.Y However, the perception oflaryngectomy as a disastrous event has not been proven by data. List et al 23 and Eadie and Bowker" suggested that the ability to cope with impairments produced by laryngectomy shortens early differences compared with organ preservation in QOL scores.
In periodic assessments, Deleyiannis et aF5found that QOL scores return to values similar to the presurgical stage after 2 years postlaryngectomy, whereas Hammerlid et aF6found that a l-year period is sufficient to compensate for the acute effects of treatment on QOL score. Therefore, although functional limitations persist over time, the overall QOL scores reach those that are similar to those ofother diseases with an intact larynx. 27 In our study, we found that the UW-QOL instrument could define the specific ailments that decrease QOL in patientswith head andneckcancerwhohad undergone (or had not undergone) laryngectomy. For patients who have undergone laryngectomy, the importance of appearance due to the scar, neck deformity produced by the surgery, and the presence of a definitive tracheostomy in the neck were ranked as important domains that affect QOL.
Thetaste factor also ranked high due to the lossof smell and the difficultyin rehabilitating this senseafter surgery. In contrast, patients in the organ preservation group revealed that saliva and swallowing were important factors in QO1.Therecreation factor ranked high in both groups and represents a new finding. No data exist that shed Discussion QOL assessment has become important in decision making for patients with head and neck cancer. The impact of a disease and its treatment is correlated with survival, ability to return to work, and social functioning." Many instruments with a general or specific focus have been designed to evaluate QOL in patients with head and neck cancer. Although generic QOL instruments can be used in a wide range of patients with different types of tumors, they lack responsiveness for specific ailments of each disease. The UW-QOL for head and neck cancer is a widely used instrument with high reliability that has been validated in the Spanish language, which enables its use in populations of developing countries in Latin America." Due to its location in the body and its close relationship with feeding, communication, and interpersonal relationships, head and neck cancer imposes an important burden on QOL. Moreover, its related treatments (chemotherapy, radiotherapy, and surgery) adversely affect functions such as swallowing, speech, breathing, and mastication, which can lead to even poorer QOL.
Since the 1990s, organ preservation protocols for patients with advanced tumors have been considered to offer outcomes similar to those of laryngectomy followed by radiotherapy, with the enormous advantage of larynx preservation and the consequent gain in QOL, as demonstrated in randomized, controlled Most of our scores were comparatively lower than those reported elsewhere. which indicates that the relative importance of domains is different in our population and that these differences should be considered when treatments are offered. In the Scotland Laryngectomy Audit. Robertson et al found a global score of72.9 with high importance for speech, swallowing, activity, mood, and appearance. 27 In our study, taste, pain, and recreation were important domains. They are not currently reported in other studies and could represent a different weight for items in the QOL questionnaire as rated by Latin American patients.
Some weaknesses of this study should be noted. The first is related to the small sample size, which can explain clinically meaningful but not statistically significant differences in some domain Scores.The second limitation is related to the design of this study. It was not a randomized trial, and treatment decisions were made by surgeons; thus, comparisons can introduce bias. Third, although a clear treatment protocol has been established, not all patients received the same treatments, doses, and procedures. All of these factors can affect the measurement of QOL. The same results were obtained by other authors.25.29·3 1 The consistency of these findings confirms that after an initial period of adaptation (as long as 2 years), patients who undergo laryngectomy reach QOL scores that are similar to those of patients treated with chemoradiotherapy and weakens the notion that laryngectomy is a disastrous event in a patient's life. This lack of difference also may be explained by the high frequency of definitive tracheostomy in the organ preservation group, which reduces the potential advantages offered by organ preservation treatments in the voice and breath domains.
In other studies, the rate of tracheostomy was approximately 30%,whereas in our study, nearly three-fourths of patients had a tracheostomy. It is impossible to discard any of these hypotheses due to the design of this study.
Most studies on QOL in laryngectomy or organ preservation protocols were performed in developed countries with specific socioeconomic and cultural characteristics. Until now, little information was available on outcomes in patients in developing countries. A study by Vilaseca et al in 49 laryngectomized patients found mean scores on the UW-QOL that ranged from 72 for taste to 89 for chewing." In our study patients, domain scores varied from 26 for speech to 80 for saliva. Reach for the best patient care I reach for Leica! V1sit us during the COSM @ booth #324,
In conclusion, in a cohort of Latin American patients with laryngeal cancer, global QOL assessments were similar when comparing laryngectomy with organ preservation protocols. Important differences in specific domains should be identified to better explain the consequences of treatment. The relevance of domains and the scores of the UW-QOL instrument differ from those reported in developed countries; thus, local evaluations of QOL should be integrated in decision making.
